Evaluate the Efficacy and Safety of the Digital Therapeutics Repeech for the Post-Stroke Dysarthria.

NANot yet recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Post-stroke Dysarthria
Interventions
DEVICE

repeech

Participants in this group will use the repeech application for a period of 4 weeks, with recommended usage of 5 days per week for 30 to 60 minutes per session. A designated speech-language pathologist (SLP) will set individualized treatment goals and customize the content of the therapy sessions based on each participant's baseline assessment. The repeech intervention will be tailored to meet the specific needs of each participant to improve speech intelligibility and communication abilities.

OTHER

Workbook

Participants in the control group will use a workbook provided by the sponsor for the treatment of dysarthria, due to the lack of a standardized care protocol for this condition. The recommended usage is the same as the treatment group: 5 days per week, for 30 to 60 minutes per session over a period of 4 weeks. After each self-treatment session, participants will record their activities on a checklist to monitor adherence and ensure compliance with the study protocol.

Trial Locations (5)

Unknown

Yongin Severance Hospital, Yongin

Ewha Womans University Mokdong Medical Center, Seoul

Ewha Womans University Seoul Medical Center, Seoul

KyunHee University Hospital, Seoul

National Rehabilitation Center, Seoul

All Listed Sponsors
lead

HAII corp.ltd

INDUSTRY

NCT06670014 - Evaluate the Efficacy and Safety of the Digital Therapeutics Repeech for the Post-Stroke Dysarthria. | Biotech Hunter | Biotech Hunter